Harvard Bioscience (HBIO) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.97 --0%
Financial Fact:
Total operating expenses: 12.5M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Total operating expenses: 12.5M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q3 EPS of ($0.02), $0.04 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $21.97 million versus the consensus estimate of $23.7 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Reinstates Zoom Video (ZM) at Buy
- BofA survey shows European fund managers eye growth despite caution
- H.C. Wainwright Reiterates Buy Rating on Intensity Therapeutics, Inc. (INTS)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
